Ozarelix
Ozarelix (D-63153) is a GnRH antagonist. Ozarelix induces cell apoptosis and arrests cell in G2/M phase. Ozarelix can be used in the research of prostate cancer.
Nos produits utilisent uniquement pour la recherche. Nous ne vendons pas aux patients.
- CAS No.: 295350-45-7
- Formule: C72H96ClN17O14
- Masse moléculaire:1459.09
-
Stockage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Activité biologique
Description
In Vitro
Ozarelix (0-20 ng/mL, 72 h) inhibits PC3 and DU145 cell proliferation[1].
Ozarelix (0-20 ng/mL, 72 h) induces apoptosis in PC3 and DU145 cells[1].
Ozarelix (20 ng/mL, 72 h) triggers caspase 8-dependent caspase 3 activation[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:Serum-starved PC3 and DU145 cells
-
Concentration:0, 5, 10, 20 ng/mL
-
Incubation Time:0, 24, 48, 72, 96 h
-
Result:Inhibited cell proliferation in a dose and time-dependent manner.
-
Cell Line:PC3 and DU145 cells
-
Concentration:0, 5, 10, 20 ng/mL
-
Incubation Time:72 h
-
Result:Increased the levels of p21 and p27 both in PC3 and DU145 cells.
Decreased levels of anti-apoptotic proteins such as Bcl2 and Bcl-Xl.
Upregulated Erk and p38MAPK activity.
Essai clinique
| NCT Number | Sponsor | Condition | Start Date |
Phase
|
|---|---|---|---|---|
| NCT01329991 | Plexxikon| | 2011-05 | PHASE1 |
Chemical Information
-
CAS No. 295350-45-7
-
Masse moléculaire 1459.09
-
Formule C72H96ClN17O14
-
Synonyms
D-63153
-
Livraison
Room temperature in continental US; may vary elsewhere.
-
Stockage
Please store the product under the recommended conditions in the Certificate of Analysis.
Pureté et documentation
Références
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)